INS and type 2 diabetes mellitus: Almost all individuals with type 1 diabetes (T1D) and approximately 40% of individuals with type 2 diabetes (T2D) experience hypoglycemia at various frequencies depending on the therapies they employ for glycemic control, with exogenous insulin therapy being associated with the highest risk for hypoglycemic exposure (1).